Aldebaran Financial Inc. Gilead Sciences, Inc. Transaction History

Aldebaran Financial Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $536,289 - $601,385	-8,668 Closed	0 $0
Q1 2019 Apr 23, 2019	SELL	$62.53 - $70.05 $418,138 - $468,424	-6,687 Reduced 43.55%	8,668 $564,000
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $32,509 - $42,423	-537 Reduced 3.38%	15,355 $960,000
Q3 2018 Nov 08, 2018	SELL	$71.28 - $78.92 $6,272 - $6,944	-88 Reduced 0.55%	15,892 $1.23 Million
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $113,539 - $132,440	-1,750 Reduced 9.87%	15,980 $1.13 Million
Q1 2018 Apr 24, 2018	SELL	$72.84 - $88.8 $9,105 - $11,100	-125 Reduced 0.7%	17,730 $1.34 Million
Q4 2017 Mar 02, 2018	BUY	$71.15 - $83.52 $42,690 - $50,112	600 Added 3.48%	17,855 $1.28 Million
Q2 2017 Aug 28, 2017	BUY	N/A	17,255	17,255 $1.22 Million

1,880

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Aldebaran Financial Inc., based on Form 13F filings with the SEC.

Stay updated on Aldebaran Financial Inc. with notifications on news.